Raiffeisen Bank International’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Sell
90,000
-20,000
-18% -$513K 0.03% 272
2026
Q1
$2.51M Sell
110,000
-30,000
-21% -$543K 0.04% 248
2025
Q4
$2.05M Buy
140,000
+22,000
+19% +$416K 0.03% 255
2025
Q3
$2.9M Sell
118,000
-22,000
-16% -$491K 0.04% 210
2025
Q2
$2.93M Sell
140,000
-20,000
-13% -$474K 0.04% 194
2025
Q1
$4.82M Buy
160,000
+40,000
+33% +$1.52M 0.08% 168
2024
Q4
$4.63M Buy
+120,000
New +$5.41M 0.07% 164

Other funds holding ACHC

Raiffeisen Bank International's ACHC Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Acadia Healthcare (ACHC) stake by 18% in Q2 2026, selling an estimated $513K and leaving 90,000 shares worth $2.49M. The position accounts for 0.03% of the portfolio, ranked #272.

Raiffeisen Bank International first reported a position in ACHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.82M in Q1 2025. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Raiffeisen Bank International held 90,000 shares of Acadia Healthcare worth $2.49M as of Q2 2026.
  • Raiffeisen Bank International sold 20,000 Acadia Healthcare shares in Q2 2026, an estimated $513K.
  • Acadia Healthcare made up 0.03% of Raiffeisen Bank International's portfolio in Q2 2026, its #272 holding.
  • Raiffeisen Bank International first reported a position in Acadia Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's Acadia Healthcare position peaked at $4.82M in Q1 2025.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.